OrthoPediatrics (NASDAQ:KIDS) Stock Rating Lowered by Wall Street Zen

OrthoPediatrics (NASDAQ:KIDS) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Other equities analysts have also recently issued research reports about the stock. Needham & Company LLC dropped their target price on shares of OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating on the stock in a research report on Wednesday, October 29th. Canaccord Genuity Group initiated coverage on OrthoPediatrics in a report on Wednesday, December 10th. They set a “buy” rating and a $24.00 price target on the stock. BTIG Research reissued a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, October 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Thursday, January 22nd. Finally, TD Cowen raised shares of OrthoPediatrics to a “strong-buy” rating in a report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, OrthoPediatrics has an average rating of “Moderate Buy” and a consensus target price of $23.89.

OrthoPediatrics Stock Performance

NASDAQ KIDS opened at $16.96 on Friday. The company has a fifty day moving average price of $17.67 and a 200-day moving average price of $18.20. The firm has a market cap of $425.36 million, a price-to-earnings ratio of -8.70 and a beta of 1.12. The company has a debt-to-equity ratio of 0.28, a current ratio of 7.40 and a quick ratio of 3.52. OrthoPediatrics has a 1 year low of $15.28 and a 1 year high of $26.40.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Grandeur Peak Global Advisors LLC purchased a new position in OrthoPediatrics in the 2nd quarter valued at approximately $452,000. Los Angeles Capital Management LLC bought a new position in shares of OrthoPediatrics in the second quarter worth $220,000. R Squared Ltd purchased a new position in shares of OrthoPediatrics in the second quarter valued at $272,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of OrthoPediatrics by 12.4% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 15,901 shares of the company’s stock valued at $342,000 after purchasing an additional 1,753 shares during the period. Finally, Russell Investments Group Ltd. lifted its holdings in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.